An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

AMALAPURAM: Health authorities in Konaseema district have reported a spike in hepatitis infections in Pallam village, following over 10 days of persistent fever ...

The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...

A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the ...

Medical experts have emphasized the importance of multidisciplinary cooperation in the management of liver diseases and the ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, ...

China has made significant progress in reducing mother-to-child transmission of hepatitis B, but further efforts are needed ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids. They ...

Brii Biosciences has reported promising interim results from its Phase II ENSURE study of elebsiran, a hepatitis B ...